Summary
Beckman Coulter, Inc. (Beckman) is a medical device company. It undertakes the manufacture and marketing of biomedical laboratory instruments, software and supplies that simplify, automate and innovate complex biomedical tests. Its products are used in a wide range of applications such as medical research, clinical trials and drug discovery, and diagnostic laboratories in hospitals. The company has three divisions, namely, Research and Discovery, Diagnostics and Industrial. It operates across the US, Canada, Europe and Asia. Its products are sold in over 160 countries worldwide. The company has an installed base of over 275,000 clinical and research systems operating in laboratories around the world. Beckman is a subsidiary of Danaher Corporation, and is headquartered in California, the US.
The company seeks to offer its customers the world's most efficient laboratories that would contribute in improving patient health and at the same time reduce the cost of care. Beckman envisages establishing its position through the development of innovative products and services and enhancement of existing ones, internal development, strong partner relationships, strategic collaborations and acquisitions.
Beckman Coulter, Inc. (BEC) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Beckman Coulter, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 7
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Beckman Coulter, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 9
Beckman Coulter, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Beckman Coulter, Inc., Medical Equipment, Deal Details 12
Asset Purchase 12
Beckman Coulter to Acquire Clinical Microbiology Business from Siemens Healthcare Diagnostics 12
Beckman Coulter Acquires Clinical Products Distribution Business From Dong-A Pharma, For US$10 Million 13
Beckman Coulter Acquires Royalty Obligation for Preeclampsia Markers From Nephromics 14
Partnerships 15
Beckman Coulter Enters Into Licensing Agreements With National University Of Ireland 15
CellaVision Expands Distribution Agreement With Beckman Coulter 16
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 17
Atonomics Enters Into An Agreement With Beckman Coulter 18
Transgene Signs Agreement With Beckman Coulter 19
Trillium Diagnostics Enters Into Co-Marketing Agreement With Beckman Coulter 20
CellaVision Enters Into Distribution Agreement With Beckman Coulter 21
Axis-Shield Enters Into An Agreement With Beckman Coulter 22
Agencourt Bioscience Enters Into An Agreement With Third Wave Technologies 23
AcroMetrix Enters Into A Partnership Agreement With Beckman Coulter 24
Beckman Coulter Signs An Agreement With Siemens Healthcare Diagnostics 25
Equity Offering 26
Beckman Coulter Completes Public Offering Of Common Stock For US$250 Million 26
Debt Offering 28
Beckman Coulter Completes Public Offering Of 6% Senior Notes For US$250 Million 28
Beckman Coulter Completes Public Offering Of 7% Senior Notes For US$250 Million 29
Acquisition 30
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 30
Danaher Completes Acquisition Of Beckman Coulter 31
Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 34
Beckman Coulter, Inc. - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 43
Legal and Regulatory 43
Nov 12, 2013: Mindray Announced a Settlement Agreement with Beckman Coulter 43
Product News 44
Oct 01, 2013: Navios Flow Cytometer from Beckman Coulter Cleared for Diagnostic Use in U.S. and China 44
Sep 26, 2013: Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems 45
Jun 19, 2013: Beckman Coulter Gets FDA 510(k) Clearance For New Access AccuTnI+3 Troponin I Assay 46
Apr 16, 2013: Beckman Coulter Launches UniCel DxH 600 Coulter Cellular Analysis System 47
Apr 05, 2013: Beckman Coulter Gets FDA Clearance For Next Generation Hemoglobin A1c Test 48
Product Approvals 49
Oct 01, 2013: Navios Flow Cytometer from Beckman Coulter Cleared for Diagnostic Use in U.S. and China 49
Sep 26, 2013: Beckman Coulter Receives FDA Clearance of AccuTnI+3 Troponin I Assay on UniCel DxI Immunoassay Systems 50
Jun 19, 2013: Beckman Coulter Gets FDA 510(k) Clearance For New Access AccuTnI+3 Troponin I Assay 51
Apr 05, 2013: Beckman Coulter Gets FDA Clearance For Next Generation Hemoglobin A1c Test 52
Other Significant Developments 53
Apr 17, 2013: Premier Awards New Contracts For Chemistry And Immunochemistry Analyzers, Automation, Reagents, Consumables And Service 53
Apr 03, 2013: Beckman Coulter Signs Six Year Agreement With Premier Healthcare Alliance To Provide Full Range Of Core Laboratory Systems And Supplies 54
Appendix 55
Methodology 55
About GlobalData 55
Contact Us 55
Disclaimer 55
List Of Tables
List of Tables
Beckman Coulter, Inc., Medical Equipment, Key Facts 1
Beckman Coulter, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Beckman Coulter, Inc., Medical Equipment Deals By Type, 2008 to YTD 2014 7
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Beckman Coulter, Inc., Deals By Market, 2008 to YTD 2014 9
Beckman Coulter, Inc., Medical Equipment, Deals Summary, 2008 to YTD 2014 10
Beckman Coulter to Acquire Clinical Microbiology Business from Siemens Healthcare Diagnostics 12
Beckman Coulter Acquires Clinical Products Distribution Business From Dong-A Pharma, For US$10 Million 13
Beckman Coulter Acquires Royalty Obligation for Preeclampsia Markers From Nephromics 14
Beckman Coulter Enters Into Licensing Agreements With National University Of Ireland 15
CellaVision Expands Distribution Agreement With Beckman Coulter 16
Radisens Diagnostics Enters Into Co-Development Agreement With Beckman Coulter For HDR Detection Technology 17
Atonomics Enters Into An Agreement With Beckman Coulter 18
Transgene Signs Agreement With Beckman Coulter 19
Trillium Diagnostics Enters Into Co-Marketing Agreement With Beckman Coulter 20
CellaVision Enters Into Distribution Agreement With Beckman Coulter 21
Axis-Shield Enters Into An Agreement With Beckman Coulter 22
Agencourt Bioscience Enters Into An Agreement With Third Wave Technologies 23
AcroMetrix Enters Into A Partnership Agreement With Beckman Coulter 24
Beckman Coulter Signs An Agreement With Siemens Healthcare Diagnostics 25
Beckman Coulter Completes Public Offering Of Common Stock For US$250 Million 26
Beckman Coulter Completes Public Offering Of 6% Senior Notes For US$250 Million 28
Beckman Coulter Completes Public Offering Of 7% Senior Notes For US$250 Million 29
Beckman Coulter Acquires Blue Ocean Biomedical From Npe Systems 30
Danaher Completes Acquisition Of Beckman Coulter 31
Beckman Coulter Completes Acquisition Of Olympus-DS From OLYMPUS 34
Beckman Coulter, Inc., Key Competitors 36
Beckman Coulter, Inc., Key Employees 37
Beckman Coulter, Inc., Other Locations 39
Beckman Coulter, Inc., Subsidiaries 41
List Of Figures
List of Figures
Beckman Coulter, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Market, 2008 to YTD 2014 1
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014 6
Beckman Coulter, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014 7
Beckman Coulter, Inc., Medical Equipment, Deals By Region, 2008 to YTD 2014 8
Beckman Coulter, Inc., Medical Equipment, Deals by Market, 2008 to YTD 2014 9
